{"name":"Lifefactors Zona Franca, SAS","slug":"lifefactors-zona-franca-sas","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"COVID-19 convalescent plasma","genericName":"COVID-19 convalescent plasma","slug":"covid-19-convalescent-plasma","indication":"Treatment of COVID-19 in patients with severe or critical illness","status":"phase_2"},{"name":"Anti-COVID-19 human immunoglobulin","genericName":"Anti-COVID-19 human immunoglobulin","slug":"anti-covid-19-human-immunoglobulin","indication":"Prevention of COVID-19 in individuals at high risk of severe disease","status":"phase_2"}]}],"pipeline":[{"name":"COVID-19 convalescent plasma","genericName":"COVID-19 convalescent plasma","slug":"covid-19-convalescent-plasma","phase":"phase_2","mechanism":"COVID-19 convalescent plasma is a treatment that uses antibodies from recovered patients to help the body fight off the SARS-CoV-2 virus.","indications":["Treatment of COVID-19 in patients with severe or critical illness"],"catalyst":""},{"name":"Anti-COVID-19 human immunoglobulin","genericName":"Anti-COVID-19 human immunoglobulin","slug":"anti-covid-19-human-immunoglobulin","phase":"phase_2","mechanism":"Anti-COVID-19 human immunoglobulin works by providing pre-formed antibodies to neutralize the SARS-CoV-2 virus.","indications":["Prevention of COVID-19 in individuals at high risk of severe disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}